Digirad Co. (NASDAQ:DRAD) Short Interest Update

Digirad Co. (NASDAQ:DRAD) was the recipient of a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 29,900 shares, a growth of 27.8% from the July 31st total of 23,400 shares. Based on an average daily volume of 11,400 shares, the short-interest ratio is currently 2.6 days. Currently, 1.6% of the shares of the stock are sold short.

Separately, ValuEngine downgraded shares of Digirad from a “buy” rating to a “hold” rating in a report on Tuesday, July 2nd.

An institutional investor recently bought a new position in Digirad stock. Weber Alan W purchased a new stake in shares of Digirad Co. (NASDAQ:DRAD) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 100,000 shares of the medical equipment provider’s stock, valued at approximately $91,000. Weber Alan W owned about 0.49% of Digirad as of its most recent SEC filing. 38.18% of the stock is currently owned by hedge funds and other institutional investors.

DRAD stock remained flat at $$4.47 during trading on Thursday. 182 shares of the company traded hands, compared to its average volume of 10,125. Digirad has a 12-month low of $4.20 and a 12-month high of $16.50. The stock has a 50 day moving average of $4.80 and a 200 day moving average of $3.13. The company has a quick ratio of 1.03, a current ratio of 1.42 and a debt-to-equity ratio of 0.77.

Digirad (NASDAQ:DRAD) last announced its quarterly earnings results on Tuesday, August 6th. The medical equipment provider reported $0.04 earnings per share (EPS) for the quarter. Digirad had a negative net margin of 5.81% and a negative return on equity of 10.97%. The firm had revenue of $25.80 million during the quarter.

Digirad Company Profile

Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through three segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services.

Read More: What is meant by buying and selling pressure?

Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.